| Year |
Citation |
Score |
| 2023 |
Medeiros D, Ayala-Baylon K, Egido-Betancourt H, Miller E, Chapleau CA, Robinson HA, Phillips ML, Yang T, Longo F, Li W, Pozzo-Miller L. A small-molecule TrkB ligand improves dendritic spine phenotypes and atypical behaviors in female Rett syndrome mice. Biorxiv : the Preprint Server For Biology. PMID 37986936 DOI: 10.1101/2023.11.09.566435 |
0.625 |
|
| 2017 |
Ferreras S, Fernández G, Danelon V, Pisano MV, Masseroni L, Chapleau CA, Krapacher FA, Mlewski EC, Mascó DH, Arias C, Pozzo-Miller L, Paglini MG. Cdk5 Is Essential for Amphetamine to Increase Dendritic Spine Density in Hippocampal Pyramidal Neurons. Frontiers in Cellular Neuroscience. 11: 372. PMID 29225566 DOI: 10.3389/Fncel.2017.00372 |
0.727 |
|
| 2016 |
Arnold M, Cross R, Singleton KS, Zlatic S, Chapleau C, Mullin AP, Rolle I, Moore CC, Theibert A, Pozzo-Miller L, Faundez V, Larimore J. The Endosome Localized Arf-GAP AGAP1 Modulates Dendritic Spine Morphology Downstream of the Neurodevelopmental Disorder Factor Dysbindin. Frontiers in Cellular Neuroscience. 10: 218. PMID 27713690 DOI: 10.3389/Fncel.2016.00218 |
0.73 |
|
| 2013 |
Bello O, Blair K, Chapleau C, Larimore JL. Is memantine a potential therapeutic for Rett syndrome? Frontiers in Neuroscience. 7: 245. PMID 24381538 DOI: 10.3389/fnins.2013.00245 |
0.319 |
|
| 2013 |
Chapleau CA, Lane J, Larimore J, Li W, Pozzo-Miller L, Percy AK. Recent Progress in Rett Syndrome and MeCP2 Dysfunction: Assessment of Potential Treatment Options. Future Neurology. 8. PMID 24348096 DOI: 10.2217/Fnl.12.79 |
0.684 |
|
| 2013 |
Chapleau CA, Lane J, Pozzo-Miller L, Percy AK. Evaluation of current pharmacological treatment options in the management of Rett syndrome: from the present to future therapeutic alternatives. Current Clinical Pharmacology. 8: 358-69. PMID 24050745 DOI: 10.2174/15748847113086660069 |
0.638 |
|
| 2013 |
Larimore J, Ryder PV, Kim KY, Ambrose LA, Chapleau C, Calfa G, Gross C, Bassell GJ, Pozzo-Miller L, Smith Y, Talbot K, Park IH, Faundez V. MeCP2 regulates the synaptic expression of a Dysbindin-BLOC-1 network component in mouse brain and human induced pluripotent stem cell-derived neurons. Plos One. 8: e65069. PMID 23750231 DOI: 10.1371/Journal.Pone.0065069 |
0.762 |
|
| 2013 |
Pitcher MR, Ward CS, Arvide EM, Chapleau CA, Pozzo-Miller L, Hoeflich A, Sivaramakrishnan M, Saenger S, Metzger F, Neul JL. Insulinotropic treatments exacerbate metabolic syndrome in mice lacking MeCP2 function. Human Molecular Genetics. 22: 2626-33. PMID 23462290 DOI: 10.1093/hmg/ddt111 |
0.624 |
|
| 2013 |
Arnold JJ, Hansen MS, Gorman GS, Inoue T, Rao V, Spellen S, Hunsinger RN, Chapleau CA, Pozzo-Miller L, Stamer WD, Challa P. The effect of Rho-associated kinase inhibition on the ocular penetration of timolol maleate. Investigative Ophthalmology & Visual Science. 54: 1118-26. PMID 23307957 DOI: 10.1167/Iovs.12-10583 |
0.572 |
|
| 2012 |
Chapleau CA, Boggio EM, Calfa G, Percy AK, Giustetto M, Pozzo-Miller L. Hippocampal CA1 pyramidal neurons of Mecp2 mutant mice show a dendritic spine phenotype only in the presymptomatic stage. Neural Plasticity. 2012: 976164. PMID 22919518 DOI: 10.1155/2012/976164 |
0.787 |
|
| 2012 |
Chapleau CA, Pozzo-Miller L. Divergent roles of p75NTR and Trk receptors in BDNF's effects on dendritic spine density and morphology. Neural Plasticity. 2012: 578057. PMID 22548193 DOI: 10.1155/2012/578057 |
0.706 |
|
| 2012 |
Calfa G, Chapleau CA, Campbell S, Inoue T, Morse SJ, Lubin FD, Pozzo-Miller L. HDAC activity is required for BDNF to increase quantal neurotransmitter release and dendritic spine density in CA1 pyramidal neurons. Hippocampus. 22: 1493-500. PMID 22161912 DOI: 10.1002/Hipo.20990 |
0.765 |
|
| 2009 |
Chapleau CA, Larimore JL, Theibert A, Pozzo-Miller L. Modulation of dendritic spine development and plasticity by BDNF and vesicular trafficking: fundamental roles in neurodevelopmental disorders associated with mental retardation and autism. Journal of Neurodevelopmental Disorders. 1: 185-96. PMID 19966931 DOI: 10.1007/S11689-009-9027-6 |
0.728 |
|
| 2009 |
Chapleau CA, Calfa GD, Lane MC, Albertson AJ, Larimore JL, Kudo S, Armstrong DL, Percy AK, Pozzo-Miller L. Dendritic spine pathologies in hippocampal pyramidal neurons from Rett syndrome brain and after expression of Rett-associated MECP2 mutations. Neurobiology of Disease. 35: 219-33. PMID 19442733 DOI: 10.1016/J.Nbd.2009.05.001 |
0.785 |
|
| 2009 |
Larimore JL, Chapleau CA, Kudo S, Theibert A, Percy AK, Pozzo-Miller L. Bdnf overexpression in hippocampal neurons prevents dendritic atrophy caused by Rett-associated MECP2 mutations. Neurobiology of Disease. 34: 199-211. PMID 19217433 DOI: 10.1016/J.Nbd.2008.12.011 |
0.738 |
|
| 2008 |
Chapleau CA, Carlo ME, Larimore JL, Pozzo-Miller L. The actions of BDNF on dendritic spine density and morphology in organotypic slice cultures depend on the presence of serum in culture media. Journal of Neuroscience Methods. 169: 182-90. PMID 18242714 DOI: 10.1016/j.jneumeth.2007.12.006 |
0.705 |
|
| 2007 |
Moore CD, Thacker EE, Larimore J, Gaston D, Underwood A, Kearns B, Patterson SI, Jackson T, Chapleau C, Pozzo-Miller L, Theibert A. The neuronal Arf GAP centaurin alpha1 modulates dendritic differentiation. Journal of Cell Science. 120: 2683-93. PMID 17635995 DOI: 10.1242/Jcs.006346 |
0.681 |
|
| 2007 |
Amaral MD, Chapleau CA, Pozzo-Miller L. Transient receptor potential channels as novel effectors of brain-derived neurotrophic factor signaling: potential implications for Rett syndrome. Pharmacology & Therapeutics. 113: 394-409. PMID 17118456 DOI: 10.1016/J.Pharmthera.2006.09.005 |
0.753 |
|
| Show low-probability matches. |